The emergence of “cancer energy metabolism” as one of the promising targets, is affirmed by the two significant Pharma deals this year:
Oncology targets, strategies, cancer drug development and personalized medicine
Showing posts with label PKM2. Show all posts
Showing posts with label PKM2. Show all posts
Thursday, December 16, 2010
Subscribe to:
Posts (Atom)